TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ImmunoIVD AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
33,069
|
28,314
|
25,674 |
Financial expenses |
1,134
|
1,056
|
967 |
Earnings before taxes |
2,959
|
3,715
|
-2,056 |
EBITDA |
5,390
|
6,399
|
397 |
Total assets |
22,093
|
20,876
|
18,325 |
Current assets |
17,910
|
16,757
|
12,851 |
Current liabilities |
16,674
|
16,124
|
18,226 |
Equity capital |
5,420
|
4,752
|
99 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
25
|
23
|
26 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.5%
|
22.8%
|
0.5% |
Turnover per employee |
1,323
|
1,231
|
987 |
Profit as a percentage of turnover |
8.9%
|
13.1%
|
-8.0% |
Return on assets (ROA) |
18.5%
|
22.9%
|
-5.9% |
Current ratio |
107.4%
|
103.9%
|
70.5% |
Return on equity (ROE) |
54.6%
|
78.2%
|
-2076.8% |
Change turnover |
4,610
|
4,720
|
9,776 |
Change turnover % |
16%
|
20%
|
61% |
Chg. No. of employees |
2
|
-3
|
5 |
Chg. No. of employees % |
9%
|
-12%
|
24% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.